Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagaraj M Kulkarni

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Journal of Pharmacology|October 19, 2006
Elevation of systolic blood pressure in an animal model of olanzapine induced weight gainBasanagouda M Patil, Nagaraj M Kulkarni, Banappa S Unger
ACS Omega|March 3, 2025
Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue DesignA S Ben Geoffrey, Deepak Agrawal, Nagaraj M Kulkarni, et al.
International Immunopharmacology|February 8, 2011
Embelin ameliorates dextran sodium sulfate-induced colitis in miceKalyan Kumar G, Dhamotharan R, Nagaraj M Kulkarni, et al.
ACS Omega|March 25, 2024
PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC DesignBen Geoffrey A S, Deepak Agrawal, Nagaraj M Kulkarni, et al.
European Journal of Pharmacology|May 10, 2011
Embelin reduces cutaneous TNF-α level and ameliorates skin edema in acute and chronic model of skin inflammation in miceG Kalyan Kumar, R Dhamotharan, Nagaraj M Kulkarni, et al.
European Journal of Pharmacology|July 26, 2015
Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivoSaranya Nidhyanandan, Thippeswamy S Boreddy, Kothapalli B Chandrasekhar, et al.
Drug Metabolism and Personalized Therapy|August 14, 2016
Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver diseaseNagaraj M Kulkarni, Sandeep Malampati, Mahamad Yunnus A Mahat, et al.
Hepatology Communications|July 19, 2021
STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in HepatocytesMara Caputo, Emmelie Cansby, Sima Kumari, et al.
Anti-Cancer Drugs|July 21, 2017
Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenograftsSaranya Nidhyanandan, Boreddy S Thippeswamy, Kottapalli B Chandrasekhar, et al.
Indian Journal of Pharmacology|February 20, 2014
Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 miceJeyamurugan Mookkan, Soumita De, Pranesha Shetty, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Pharmacology|October 19, 2006
Elevation of systolic blood pressure in an animal model of olanzapine induced weight gainBasanagouda M Patil, Nagaraj M Kulkarni, Banappa S Unger
ACS Omega|March 3, 2025
Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue DesignA S Ben Geoffrey, Deepak Agrawal, Nagaraj M Kulkarni, et al.
International Immunopharmacology|February 8, 2011
Embelin ameliorates dextran sodium sulfate-induced colitis in miceKalyan Kumar G, Dhamotharan R, Nagaraj M Kulkarni, et al.
ACS Omega|March 25, 2024
PROTAC-Design-Evaluator (PRODE): An Advanced Method for In-Silico PROTAC DesignBen Geoffrey A S, Deepak Agrawal, Nagaraj M Kulkarni, et al.
European Journal of Pharmacology|May 10, 2011
Embelin reduces cutaneous TNF-α level and ameliorates skin edema in acute and chronic model of skin inflammation in miceG Kalyan Kumar, R Dhamotharan, Nagaraj M Kulkarni, et al.
European Journal of Pharmacology|July 26, 2015
Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivoSaranya Nidhyanandan, Thippeswamy S Boreddy, Kothapalli B Chandrasekhar, et al.
Drug Metabolism and Personalized Therapy|August 14, 2016
Altered pharmacokinetics of rosiglitazone in a mouse model of non-alcoholic fatty liver diseaseNagaraj M Kulkarni, Sandeep Malampati, Mahamad Yunnus A Mahat, et al.
Hepatology Communications|July 19, 2021
STE20-Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in HepatocytesMara Caputo, Emmelie Cansby, Sima Kumari, et al.
Anti-Cancer Drugs|July 21, 2017
Enhanced anticancer efficacy of histone deacetyl inhibitor, suberoylanilide hydroxamic acid, in combination with a phosphodiesterase inhibitor, pentoxifylline, in human cancer cell lines and in-vivo tumor xenograftsSaranya Nidhyanandan, Boreddy S Thippeswamy, Kottapalli B Chandrasekhar, et al.
Indian Journal of Pharmacology|February 20, 2014
Combination of vildagliptin and rosiglitazone ameliorates nonalcoholic fatty liver disease in C57BL/6 miceJeyamurugan Mookkan, Soumita De, Pranesha Shetty, et al.
Pageof 2